Minerva Neurosciences, Inc - Common Stock — 財務諸表 (NASDAQ:NERV) | MetaTrader

チャート全体を表示 Full chart

ニュース

All You Need to Know About Minerva Neurosciences (NERV) Rating Upgrade to Buy

Minerva Neurosciences (NERV) Loses 37.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

H.C. Wainwright、治験デザインを評価しMinerva Neurosciences目標株価を引き上げ

H.C. Wainwright raises Minerva Neurosciences price target on trial design

Minerva Neurosciences, Inc. (NERV) Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia Transcript

ミネルバ・ニューロサイエンスが統合失調症専門家を取締役会に任命

Minerva Neurosciences appoints schizophrenia expert to board of directors

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.47%

Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial - Minerva Neurosciences (NASDAQ:NERV)

ミネルバ・ニューロサイエンス株、2億ドルの資金調達で急騰

Minerva Neurosciences stock soars after securing $200 million financing

US Stocks Mixed; Coca-Cola Posts Upbeat Earnings - American Rebel Holdings (NASDAQ:AREB), Beyond Meat (NASDAQ:BYND)